AsedaSciences and GenEvolutioN Announce Sales & Marketing Agreement to Integrate Genotoxicity Screen into 3RnD Platform
STOCKHOLM, SWEDEN, January 27, 2026 - AsedaSciences AB, an AI-driven company advancing the future of chemical safety assessment, and GenEvolutioN AG, an innovative provider of genotoxicity testing solutions, today announced a Sales & Marketing Agreement to integrate GenEvolutioN's best-in-class Micronucleus genotoxicity screen into AsedaSciences' 3RnD platform. The agreement brings GenEvolutioN's validated in vitro micronucleus assay—widely recognized for its reliability and predictive accuracy—into the 3RnD ecosystem. This addition strengthens 3RnD as a unified digital platform for chemical safety decision-making, enabling users to access critical genotoxicity data within a streamlined, AI-enhanced workflow.
"Genotoxicity screening is a cornerstone of chemical safety, and GenEvolutioN's micronucleus assay sets the industry standard," said Brad Calvin, CEO of AsedaSciences. "This partnership enables 3RnD users to leverage high-quality genotoxicity data alongside predictive analytics, supporting smarter and faster safety assessments."
Dr. Tanja Schwerdtle, CEO of GenEvolutioN, added: "We are excited to collaborate with AsedaSciences to expand access to our Micronucleus assay. Integrating our validated screening technology into the 3RnD platform will help researchers make well-informed, data-driven decisions earlier in the development process."
The integration of GenEvolutioN's genotoxicity screen aligns with AsedaSciences' mission to provide comprehensive, AI-driven tools that support the transition to New Approach Methodologies (NAMs) in chemical safety science.
About AsedaSciences
AsedaSciences is a pioneering AI-driven company focused on transforming chemical safety assessment. Through its innovative 3RnD platform, AsedaSciences integrates advanced predictive analytics, curated safety data, and New Approach Methodologies (NAMs) to empower researchers and organizations in making informed decisions about chemical safety. Committed to advancing human-relevant science, AsedaSciences supports global efforts to reduce reliance on animal testing while accelerating the development of safer chemicals and products.
About GenEvolutioN
GenEvolutioN AG is a leading provider of innovative genotoxicity testing solutions, specializing in the development of high-quality in vitro assays for the pharmaceutical, chemical, and cosmetics industries. The company's flagship Micronucleus assay is recognized for its exceptional reliability and predictive accuracy, supporting regulatory compliance and early-stage safety decision-making worldwide.
